| | Publication Year | Title | Author(s) |
| 1 | 22-Nov-2019 | Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets. | Lau, David K ; Mouradov, Dmitri; Wasenang, Wiphawan; Luk, Ian Y; Scott, Cameron M; Williams, David S ; Yeung, Yvonne H ; Limpaiboon, Temduang; Iatropoulos, George F ; Jenkins, Laura J; Reehorst, Camilla M; Chionh, Fiona; Nikfarjam, Mehrdad ; Croagh, Daniel; Dhillon, Amardeep S; Weickhardt, Andrew J ; Muramatsu, Toshihide; Saito, Yoshimasa; Tebbutt, Niall C ; Sieber, Oliver M; Mariadason, John M |
| 2 | 4-Sep-2019 | Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. | Burzykowski, Tomasz; Coart, Elisabeth; Saad, Everardo D; Shi, Qian; Sommeijer, Dirkje W; Bokemeyer, Carsten; Díaz-Rubio, Eduardo; Douillard, Jean-Yves; Falcone, Alfredo; Fuchs, Charles S; Goldberg, Richard M; Hecht, J Randolph; Hoff, Paulo M; Hurwitz, Herbert; Kabbinavar, Fairooz F; Koopman, Miriam; Maughan, Timothy S; Punt, Cornelis J A; Saltz, Leonard; Schmoll, Hans-Joachim; Seymour, Matthew T; Tebbutt, Niall C ; Tournigand, Christophe; Van Cutsem, Eric; de Gramont, Aimery; Zalcberg, John R; Buyse, Marc |
| 3 | Jun-2019 | Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial. | Tapia Rico, Gonzalo; Price, Timothy; Tebbutt, Niall C ; Hardingham, Jennifer; Lee, Chee; Buizen, Luke; Wilson, Kate; Gebski, Val; Townsend, Amanda |
| 4 | 16-Apr-2019 | Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial. | Eng, Cathy; Kim, Tae Won; Bendell, Johanna; Argilés, Guillem; Tebbutt, Niall C ; Di Bartolomeo, Maria; Falcone, Alfredo; Fakih, Marwan; Kozloff, Mark; Segal, Neil H; Sobrero, Alberto; Yan, Yibing; Chang, Ilsung; Uyei, Anne; Roberts, Louise; Ciardiello, Fortunato |
| 5 | Apr-2019 | Systemic treatment of advanced hepatocellular cancer: new hope on the horizon. | Chang Lee, Rachael; Tebbutt, Niall C |
| 6 | Mar-2019 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christos; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 7 | Dec-2018 | Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. | Shapiro, Jeremy D; Thavaneswaran, Subotheni; Underhill, Craig R; Robledo, Kristy P; Karapetis, Christos S; Day, Fiona L; Nott, Louise M; Jefford, Michael; Chantrill, Lorraine A; Pavlakis, Nick; Tebbutt, Niall C ; Price, Timothy J; Khasraw, Mustafa; Van Hazel, Guy A; Waring, Paul M; Tejpar, Sabine; Simes, John; Gebski, Val J; Desai, Jayesh; Segelov, Eva |
| 8 | Dec-2018 | Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response. | Sud, S; O'Callaghan, C ; Jonker, C; Karapetis, C; Price, T; Tebbutt, Niall C ; Shapiro, J; Van Hazel, G; Pavlakis, N; Gibbs, P; Jeffrey, M; Siu, L; Gill, S; Wong, R ; Jonker, D; Tu, D; Goodwin, R |
| 9 | 28-Nov-2018 | Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20. | Wells, J Connor; Tu, Dongsheng; Siu, Lillian L; Shapiro, Jeremy D; Jonker, Derek J; Karapetis, Christopher S; Simes, John; Liu, Geoffrey; Price, Timothy J; Tebbutt, Niall C ; O'Callaghan, Chris J |
| 10 | 1-Nov-2018 | The prognostic impact of Consensus Molecular Subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial. | Mooi, Jennifer K ; Wirapati, P; Asher, R; Lee, C K; Savas, P S; Price, T J; Townsend, A; Hardingham, J; Buchanan, D; Williams, D ; Tejpar, S; Mariadason, John M ; Tebbutt, Niall C |
| 11 | Nov-2018 | Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database. | Salem, Mohamed E; Yin, Jun; Weinberg, Benjamin A; Renfro, Lindsay A; Pederson, Levi D; Maughan, Timothy S; Adams, Richard A; Van Cutsem, Eric; Falcone, Alfredo; Tebbutt, Niall C ; Seymour, Matthew T; Díaz-Rubio, Eduardo; Aranda, Enrique; Bokemeyer, Carsten; Heinemann, Volker; Wasan, Harpreet; de Gramont, Aimery; Grothey, Axel; Shi, Qian; Sargent, Daniel J; Marshall, John L |
| 12 | Oct-2018 | Targeted therapy for metastatic colorectal cancer. | Price, Timothy J; Tang, Monica; Gibbs, Peter; Haller, Daniel G; Peeters, Marc; Arnold, Dirk; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew; Shapiro, Jeremy |
| 13 | 1-Jun-2018 | Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project. | Sjoquist, Katrin M; Renfro, Lindsay A; Simes, R John; Tebbutt, Niall C ; Clarke, Stephen; Seymour, Matthew T; Adams, Richard A; Maughan, Timothy S; Saltz, Leonard; Goldberg, Richard M; Schmoll, Hans-Joachim; Van Cutsem, Eric; Douillard, Jean-Yves; Hoff, Paulo M; Hecht, Joel Randolph; Tournigand, Christophe; Punt, Cornelis J A; Koopman, Miriam; Hurwitz, Herbert; Heinemann, Volker; Falcone, Alfredo; Porschen, Rainer; Fuchs, Charles; Diaz-Rubio, Eduardo; Aranda, Enrique; Bokemeyer, Carsten; Souglakos, Ioannis; Kabbinavar, Fairooz F; Chibaudel, Benoist; Meyers, Jeffrey P; Sargent, Daniel J; de Gramont, Aimery; Zalcberg, John R |
| 14 | Apr-2018 | Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. | Tang, Monica; Price, Timothy Jay; Shapiro, Jeremy; Gibbs, Peter; Haller, Daniel G; Arnold, Dirk; Peeters, Marc; Segelov, Eva; Roy, Amitesh; Tebbutt, Niall C ; Pavlakis, Nick; Karapetis, Chris; Burge, Matthew |
| 15 | Apr-2018 | Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer. | Elander, N O; Aughton, K; Ghaneh, P; Neoptolemos, J P; Palmer, D H; Cox, T F; Campbell, F; Costello, E; Halloran, C M; Mackey, J R; Scarfe, A G; Valle, J W; McDonald, A C; Carter, R; Tebbutt, Niall C ; Goldstein, D; Shannon, J; Dervenis, C; Glimelius, B; Deakin, M; Charnley, R M; Anthoney, Alan; Lerch, M M; Mayerle, J; Oláh, A; Büchler, M W; Greenhalf, W |
| 16 | Apr-2018 | Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. | Lau, David K ; Tay, Rebecca Y; Yeung, Yvonne H ; Chionh, Fiona; Mooi, Jennifer; Murone, Carmel ; Skrinos, Effie; Price, Timothy J; Mariadason, John M ; Tebbutt, Niall C |
| 17 | 31-Jan-2018 | Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial. | Jonker, Derek J; Nott, Louise; Yoshino, Takayuki; Gill, Sharlene; Shapiro, Jeremy; Ohtsu, Atsushi; Zalcberg, John; Vickers, Michael M; Wei, Alice C; Gao, Yuan; Tebbutt, Niall C ; Markman, Ben; Price, Timothy; Esaki, Taito; Koski, Sheryl; Hitron, Matthew; Li, Wei; Li, Youzhi; Magoski, Nadine M; Li, Chiang J; Simes, John; Tu, Dongsheng; O'Callaghan, Christopher J |
| 18 | 29-Jan-2018 | DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis. | Tögel, Lars; Nightingale, Rebecca; Wu, Rui; Chüeh, Anderly C; Al-Obaidi, Sheren; Luk, Ian; Dávalos-Salas, Mercedes; Chionh, Fiona; Murone, Carmel ; Buchanan, Daniel D; Chatterton, Zac; Sieber, Oliver M; Arango, Diego; Tebbutt, Niall C ; Williams, David; Dhillon, Amardeep S; Mariadason, John M |
| 19 | 2018 | Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. | Elander, N O; Aughton, K; Ghaneh, P; Neoptolemos, J P; Palmer, D H; Cox, T F; Campbell, F; Costello, E; Halloran, C M; Mackey, J R; Scarfe, A G; Valle, J W; McDonald, A C; Carter, R; Tebbutt, Niall C ; Goldstein, D; Shannon, J; Dervenis, C; Glimelius, B; Deakin, M; Charnley, R M; Anthoney, A; Lerch, M M; Mayerle, J; Oláh, A; Büchler, M W; Greenhalf, W |
| 20 | 1-Dec-2017 | ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer. | Pietrantonio, Filippo; Di Nicolantonio, Federica; Schrock, Alexa B; Lee, Jeeyun; Tejpar, Sabine; Sartore-Bianchi, Andrea; Hechtman, Jaclyn F; Christiansen, Jason; Novara, Luca; Tebbutt, Niall C ; Fucà, Giovanni; Antoniotti, Carlotta; Kim, Seung Tae; Murphy, Danielle; Berenato, Rosa; Morano, Federica; Sun, James; Min, Bosun; Stephens, Philip J; Chen, Marissa; Lazzari, Luca; Miller, Vincent A; Shoemaker, Robert; Amatu, Alessio; Milione, Massimo; Ross, Jeffrey S; Siena, Salvatore; Bardelli, Alberto; Ali, Siraj M; Falcone, Alfredo; de Braud, Filippo; Cremolini, Chiara |